CS MEDICA A/S Stock

Equities

End-of-day quote NORDIC GROWTH MARKET Other stock markets 18:00:00 2024-06-25 EDT			5-day change	1st Jan Change
4.766 ^DKK	+0.22%		-3.55%	+1.78%

06-17	CS Medica Completes Cannabidiol Medical Device Registration Process in Israel	MT
06-12	CS Medica to Boost Denmark Operations With OneMed Partnership	MT

Duration

Period

Style

CS Medica Completes Cannabidiol Medical Device Registration Process in Israel	06-17	MT
CS Medica to Boost Denmark Operations With OneMed Partnership	06-12	MT
CS MEDICA Announces Strategic Partnership with OneMed	06-12	CI
CS Medica, GP Europe Sign Letter of Intent for Potential Hemp Products Partnership	06-11	MT
CS Medica A/S Announces Strategic Expansion Through Innovation and Collaboration	06-11	CI
CS Medica Advances Spin-off, Listing Plans in Germany for Cannordic Unit	06-10	MT
CS Medica A/S agreed to Spin-Off Cannordic A/S.	06-09	CI
Transcript : CS Medica A/S, H1 2024 Earnings Call, May 23, 2024	05-23
CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-17	CI
CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany	04-30	CI
CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy	04-22	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Apr 12, 2024	04-12
CS Medica A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia	04-04	CI
Transcript : CS Medica A/S, 2023 Earnings Call, Feb 21, 2024	02-21
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN into Jordan	02-20	CI

05-23

CS MEDICA: CS MEDICA Group Completes Product Registration of CANNASEN® CBD-Infused Medical Devices in Israel	06-17	PU
CS MEDICA Group Achieves Complete Registration of CANNASEN® CBD-Infused Medical Devices in Israel	06-17	EQ
CS MEDICA Group Completes Product Registration of CANNASEN® CBD-Infused Medical Devices in Israel	06-17	AQ
CS MEDICA: CS MEDICA Announces Strategic Partnership with OneMed	06-12	PU
CS MEDICA Announces Strategic Partnership with OneMed	06-12	AQ

CS MEDICA Group erhält Zulassung seines kompletten Portfolios aus der CANNASEN® Produktreihe CBD-haltiger Therapien in Israel	06-17
CS MEDICA Group erhält Zulassung seines kompletten Portfolios aus der CANNASEN® Produktreihe CBD-haltiger Therapien in Israel	06-17
CS MEDICA A/S plant Ausgliederung und Börsengang von CANNORDIC A/S	06-10
CS MEDICA A/S plant Ausgliederung und Börsengang von CANNORDIC A/S	06-10